Background:We aimed at describing the efficacy of azathioprine (AZA) in pediatric ulcerative colitis, comparing the outcomes of early (0-6 months) versus late (6-24 months) initiation of therapy.Methods:Children with ulcerative colitis treated with AZA within 24 months of diagnosis were included. Corticosteroid (CS)-free remission and mucosal healing (MH), assessed by endoscopy or fecal calprotectin, at 12 months were the primary outcomes. Patients were also compared for CS-free remission and MH, need for treatment escalation or surgery, number of hospitalizations, and adverse events during a 24-month follow-up.Results:A total of 121 children entered the study (median age 10.5 4.0 years, 59% girls). Seventy-six (63%) started AZA between 0 and 6 months (early group) and 45 (37%) started between 6 and 24 months (late group). Seventy-five percent and 53% of patients in the early and late group, respectively, received CS at the diagnosis (P = 0.01). CS-free remission at 1 year was achieved by 30 (50%) of the early and 23 (57%) of the late patients (P = 0.54). MH occurred in 37 (37%) patients at 1 year, with no difference between the 2 groups (33% early, 42% late; P = 0.56). No difference was found for the other outcomes.Conclusions:Introduction of AZA within 6 months of diagnosis seems not more effective than later treatment to achieve CS-free remission in pediatric ulcerative colitis. MH does not depend on the timing of AZA initiation; however, because of the incomplete comparability of the 2 groups at the diagnosis and the use of fecal calprotectin as a surrogate marker of MH, our results should be further confirmed by prospective studies.

Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis / Aloi, Marina; D'Arcangelo, Giulia; Bramuzzo, Matteo; Gasparetto, Marco; Martinelli, Massimo; Alvisi, Patrizia; Illiceto, Maria Teresa; Valenti, Simona; Distante, Manuela; Pellegrino, Salvatore; Gatti, Simona; Arrigo, Serena; Civitelli, Fortunata; Martelossi, Stefano. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 22:7(2016), pp. 1647-1654. [10.1097/MIB.0000000000000828]

Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis

ALOI, MARINA
;
D'ARCANGELO, GIULIA;DISTANTE, MANUELA;CIVITELLI, FORTUNATA;
2016

Abstract

Background:We aimed at describing the efficacy of azathioprine (AZA) in pediatric ulcerative colitis, comparing the outcomes of early (0-6 months) versus late (6-24 months) initiation of therapy.Methods:Children with ulcerative colitis treated with AZA within 24 months of diagnosis were included. Corticosteroid (CS)-free remission and mucosal healing (MH), assessed by endoscopy or fecal calprotectin, at 12 months were the primary outcomes. Patients were also compared for CS-free remission and MH, need for treatment escalation or surgery, number of hospitalizations, and adverse events during a 24-month follow-up.Results:A total of 121 children entered the study (median age 10.5 4.0 years, 59% girls). Seventy-six (63%) started AZA between 0 and 6 months (early group) and 45 (37%) started between 6 and 24 months (late group). Seventy-five percent and 53% of patients in the early and late group, respectively, received CS at the diagnosis (P = 0.01). CS-free remission at 1 year was achieved by 30 (50%) of the early and 23 (57%) of the late patients (P = 0.54). MH occurred in 37 (37%) patients at 1 year, with no difference between the 2 groups (33% early, 42% late; P = 0.56). No difference was found for the other outcomes.Conclusions:Introduction of AZA within 6 months of diagnosis seems not more effective than later treatment to achieve CS-free remission in pediatric ulcerative colitis. MH does not depend on the timing of AZA initiation; however, because of the incomplete comparability of the 2 groups at the diagnosis and the use of fecal calprotectin as a surrogate marker of MH, our results should be further confirmed by prospective studies.
2016
azathioprine; children; mucosal healing; ulcerative colitis; immunology and allergy; gastroenterology
01 Pubblicazione su rivista::01a Articolo in rivista
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis / Aloi, Marina; D'Arcangelo, Giulia; Bramuzzo, Matteo; Gasparetto, Marco; Martinelli, Massimo; Alvisi, Patrizia; Illiceto, Maria Teresa; Valenti, Simona; Distante, Manuela; Pellegrino, Salvatore; Gatti, Simona; Arrigo, Serena; Civitelli, Fortunata; Martelossi, Stefano. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 22:7(2016), pp. 1647-1654. [10.1097/MIB.0000000000000828]
File allegati a questo prodotto
File Dimensione Formato  
Aloi_Effect of early_2016.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 417.59 kB
Formato Adobe PDF
417.59 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/898394
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 14
social impact